COMPARISON OF HGH OR HUMAN GROWTH HORMONE THERAPY BENEFITS, COST AND PERMISSIBLE USES WITH THOSE OF SERMORELIN ACETATE GROWTH HORMONE RELEASING HORMONE

HGH or Human Growth Hormone Therapy and Sermorelin GHRH Therapy Provide Similar Treatment Benefits

Human growth hormone therapy and Sermorelin growth hormone releasing hormone therapy have substantially the same treatment benefits because injected recombinant human growth hormone (somatropin) medication is genetically engineered to have the same DNA structure as human growth hormone produced by the pituitary gland when stimulated by Sermorelin acetate growth hormone releasing hormone injections. The benefits of Sermorelin therapy or recombinant human growth hormone therapy include the following:

• Increases the development of lean body mass through the development of new muscle cells
• Reduces body fat through lipolysis
• Increases energy and vitality
• Increases strength
• Increases endurance
• Accelerates healing from wounds or surgery
• Strengthens the heart
• Enhances the immune system
• Increases IGF-1 production
• Improves sleep quality
• Increases calcium retention, and strengthens and increases the mineralization of bone or bone density.
• Increases protein synthesis and stimulates the growth of all internal organs except the brain.

Sermorelin Growth Hormone Releasing Hormone (GH-RH) Therapy Costs Less Than Synthetic or Recombinant Human Growth Hormone (Somatropin) Therapy

The cost of Sermorelin therapy is typically less than one half the cost of recombinant human growth hormone (somatropin) therapy due to the higher cost of the genetically engineered human growth hormone medication.

Federal Law Restricts the Use of HGH or Recombinant Human Growth Hormone (Somatropin) to Only Those Medical Uses Specifically Approved by the Secretary of Health and Human Services

Sermorelin acetate may be prescribed for an unlabeled use at the discretion of a treating physician, but HGH or recombinant human growth hormone may not be prescribed for any unapproved or unlabeled use.

The applicable law concerning the knowing possession or distribution of human growth hormone for any unapproved purpose is set forth in US Code Annotated, Title 21 Food and Drugs, Chapter 3 Subchapter III, Section 333. (e) (1).

This statute provides in relevant part that "...whoever knowingly distributes, or possesses with the intent to distribute, human growth hormone for any use in humans other than the treatment of a disease or other recognized medical condition, where such use has been authorized by the Secretary of Health and Human Services under section 355 of this title pursuant to the order of a physician, is guilty of an offense punishable by not more than 5 years in prison, such fines as are authorized by Title 18, or both.

Recombinant human growth hormone (Somatropin) has not been approved for medical use in reversing the effects of aging, treating chronic fatigue, treating obesity or reducing body fat, increasing lean muscle, enhancing athletic performance, strengthening the immune system or accelerating healing of wounds following injury or surgery.

Sermorelin Therapy is a Permissible Unlabeled Adult Medical Use of Sermorelin Acetate

National Medical Clinic, Inc. physicians who are also Members of the National Organization of American Physicians™ provide adult patients with Sermorelin therapy through the organization's Physician Referral Service. National Medical Clinic, Inc. (NMC) (http://www.nationalmedicalclinic.com) is a patient medical services management organization with a national network of physicians and other medical providers. National Medical Clinic™ manages the operations of its national physician network and physician referral service. The national physician network is known as the National Organization of American Physicians™ (NOAP™). Physicians and other providers who are members of the National Organization of American Physicians™ are also members in its Physician Referral Service™ (http://www.physicianreferralservice.org/).